4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001567619-22-017430
President and CEO sold 12,502 shares at $22.54 ($281,851)
- President and CEO acquired 12,502 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coulie Bernard President and CEO | 2022-09-12 | Option exercise | +12,502 | $2.08 | $26,004 | 71,775 | D: show line 1 in the form |
| Coulie Bernard President and CEO | 2022-09-12 | Sale | −12,502 | $22.54 | $281,851 | 59,273 | D: show line 2 in the form |
| Open-market sales · 12,502 sh · avg $22.54 · $281,851 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coulie Bernard President and CEO | 2022-09-12 | Option exercise · Stock Option (right to buy) | −12,502 | 297,380 | D: show line 3 in the form |
Loading xslF345X03/doc1.xml…